Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Mexican Stock Exchange  >  Genomma Lab Internacional SAB de CV    LAB B   MX01LA010006

GENOMMA LAB INTERNACIONAL SAB DE CV

(LAB B)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mexican Stock Exchange
06/13/2019 06/14/2019 06/17/2019 06/18/2019 06/19/2019 Date
15.89(c) 16.05(c) 16.4(c) 16.7(c) 16.83 Last
2 149 971 2 504 890 981 253 2 231 522 888 825 Volume
-1.18% +1.01% +2.18% +1.83% +0.78% Change
More quotes
Financials (MXN)
Sales 2019 12 777 M
EBIT 2019 2 615 M
Net income 2019 1 299 M
Debt 2019 4 023 M
Yield 2019 1,88%
Sales 2020 13 659 M
EBIT 2020 3 042 M
Net income 2020 1 501 M
Debt 2020 3 559 M
Yield 2020 -
P/E ratio 2019 11,15
P/E ratio 2020 9,39
EV / Sales2019 1,64x
EV / Sales2020 1,50x
Capitalization 16 946 M
More Financials
Company
Genomma Lab Internacional SAB de CV is a Mexico-based over-the-counter pharmaceutical (OTC pharmaceutical), generic drugs (GD) and personal care products company. The Company is engaged in the development, distribution and marketing of a range of products within different brands, for such... 
Sector
Pharmaceuticals
Calendar
07/25Earnings Release
More about the company
Surperformance© ratings of Genomma Lab Internacional
Trading Rating : Investor Rating :
More Ratings
Latest news on GENOMMA LAB INTERNACIONAL
2018GENOMMA LAB INTERNACIONAL DE CV : IFC and IDB Invest Will Provide a US$100 Milli..
AQ
2013GENOMMA LAB INTERNACIONAL SAB DE CV : Anuncio Wal-mart - TCP
PU
2013GENOMMA LAB INTERNACIONAL SAB DE CV : quaterly earnings release
2013Mexico's Genomma Lab to Sell Products in U.S. Wal-Mart Stores
DJ
2012GENOMMA LAB INTERNACIONAL SAB DE CV : GLI Secures Committed Financing to acquire..
PU
2011GENOMMA LAB : Termination of XL-3 License Agreement
PU
More news
Analyst Recommendations on GENOMMA LAB INTERNACIONAL
More recommendations
Sector news : Pharmaceuticals - NEC
06/19PFIZER : Fitch Puts Pfizer on Watch Negative, Notes Leverage Increase
DJ
06/19GLAXOSMITHKLINE : GSK kicks off sale of $1.2 billion consumer health drugs - sou..
RE
06/19CEOs of some U.S. firms to meet Chinese Premier Li this week - Bloomberg
RE
06/19SANOFI : plans 466 job cuts as part of R&D reshuffle
RE
06/19GLOBAL MARKETS LIVE : Viacom, Apple, Siemens, Boeing…
More sector news : Pharmaceuticals - NEC
Chart GENOMMA LAB INTERNACIONAL SAB DE CV
Duration : Period :
Genomma Lab Internacional SAB de CV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENOMMA LAB INTERNACIONAL
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 18,3  MXN
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Jorge Luis Brake Valderrama Chief Executive Officer
Rodrigo Alonso Herrera Aspra Chairman
Antonio Zamora Galland Vice President-Administration & Finance
Juan Alonso Independent Director
Sabrina Lucila Herrera Aspra Director
Sector and Competitors
1st jan.Capitalization (M$)
GENOMMA LAB INTERNACIONAL SAB DE CV43.10%864
JOHNSON & JOHNSON8.66%348 981
PFIZER-1.33%233 072
ROCHE HOLDING LTD.14.63%227 848
NOVARTIS22.44%220 893
MERCK AND COMPANY10.57%206 641